Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
暂无分享,去创建一个
D. Spandidos | N. Sipsas | Efthalia Angelopoulou | A. Bougea | V. Georgakopoulou | Sotiria Makrodimitri | D. Basoulis | A. Gkoufa | G. Karamanakos | Aristeidis Tsakanikas
[1] D. Spandidos,et al. New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study , 2023, Medicine international.
[2] S. Papageorgiou,et al. Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease , 2023, Life.
[3] A. Koyanagi,et al. Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany. , 2022, Journal of Alzheimer's disease : JAD.
[4] D. Spandidos,et al. Onodera's prognostic nutritional index: Comparison of its role in the severity and outcomes of patients with COVID‑19 during the periods of alpha, delta and omicron variant predominance. , 2022, Experimental and therapeutic medicine.
[5] Yandeng Li,et al. Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease , 2022, Medicine.
[6] F. Taghizadeh,et al. The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19 , 2021, Revue Neurologique.
[7] M. Etemadifar,et al. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran , 2021, Parkinsonism & Related Disorders.
[8] A. Galanopoulou,et al. Outcome of Hospitalized Parkinson's Disease Patients with and without COVID‐19 , 2021, Movement disorders clinical practice.
[9] R. Gold,et al. Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany , 2021, Movement disorders : official journal of the Movement Disorder Society.
[10] A. Kurniawan,et al. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression , 2021, Parkinsonism & Related Disorders.
[11] K. Melmed,et al. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City , 2020, Neurology.
[12] I. Koralnik,et al. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients , 2020, Annals of clinical and translational neurology.
[13] A. Padovani,et al. Lifting the mask on neurological manifestations of COVID-19 , 2020, Nature Reviews Neurology.
[14] L. Tönges,et al. Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany , 2020, Neurological Research and Practice.
[15] A. Fasano,et al. COVID‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy , 2020, Movement disorders : official journal of the Movement Disorder Society.
[16] L. Romito,et al. Effects of COVID‐19 on Parkinson's Disease Clinical Features: A Community‐Based Case‐Control Study , 2020, Movement disorders : official journal of the Movement Disorder Society.
[17] K. Walters,et al. Factors associated with hospitalisation among people with Parkinson's disease - A systematic review and meta-analysis. , 2020, Parkinsonism & related disorders.
[18] P. Bugalho,et al. Motor and non-motor function predictors of mortality in Parkinson’s disease , 2019, Journal of Neural Transmission.
[19] J. Finsterer,et al. Cardiac abnormalities in Parkinson’s disease and Parkinsonism , 2018, Journal of Clinical Neuroscience.
[20] B. Guthrie,et al. Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database , 2017, BMC Neurology.
[21] A. Lees,et al. Dementia in Parkinsonism , 2011, Journal of Neural Transmission. Supplementa.